EP2616064

Ketórólaksamsetningar sem eru tilbúnar til notkunar

  • Status:
    EP Einkaleyfi fallið úr gildi
  • EP appl. date:
    21.10.2011
  • EP published:
    7.8.2019
  • EP application number:
    11835216.0
  • Max expiry date:
    20.10.2031
  • Expiry date:
    20.10.2024
  • Title:
    READY TO USE KETOROLAC FORMULATIONS

Timeline

Today
21.10.2011EP application
7.8.2019EP Publication
4.11.2019Translation submitted
15.11.2019Registration published
20.10.2024Expires

Owner

  • Name:
    Rtu Pharmaceuticals LLC
  • Address:
    840 111th Avenue, Suite 7, 34108, Naples, FL, US

Inventor

  • Name:
    PERGOLIZZI, Joseph
  • Address:
    Naples FL, US
  • Name:
    MIRONOV, Alexander
  • Address:
    Naples FL, US
  • Name:
    PICKENS, Chad, James
  • Address:
    BendOR, US
  • Name:
    JOHNSON, Douglas, Giles
  • Address:
    ArvadaCO, US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113, Reykjavík,

Priority

  • Number:
    201161481602 P
  • Date:
    2.5.2011
  • Country:
    US
  • Number:
    405384 P
  • Date:
    21.10.2010
  • Country:
    US

Classification

  • Categories:
    A61K 31/407, A61K 31/21, A61K 9/00, A61K 47/26, A61K 9/08

Annual fees

Number

Paid

Expires

Payer

Number: 9

Paid: 23.10.2019

Expires: 20.10.2020

Payer: Árnason Faktor

Number: 10

Paid: 1.10.2020

Expires: 20.10.2021

Payer: Sigurjónsson & Thor ehf.

Number: 11

Paid: 1.10.2021

Expires: 20.10.2022

Payer: Sigurjónsson & Thor ehf.

Number: 12

Paid: 3.10.2022

Expires: 20.10.2023

Payer: Patice ehf.

Number: 13

Paid: 19.10.2023

Expires: 20.10.2024

Payer: Árnason Faktor ehf.

Upload documents